Vijay Kedia Calls for Abolition of LongTerm Capital Gains Tax Citing Patient Capital for Nation Building Mastercard Partners With JDcom to Expand Global Payment Connectivity and Explore AIPowered Purchasing Solutions AI Talent Wars How Tech Giants and Startups Are Battling for the Future of Artificial Intelligence BioOrbit Launches Drug Crystallization Technology on SpaceX to Space Station Targeting SelfInjected Cancer Treatments US Jobless Claims Remain Low Signaling Labor Market Resilience The TrillionDollar Question SpaceX Starship Test and Its IPO Implications STC Q1 2026 Earnings EPS Surges Past Estimates by 485 BranchOut Food Inc BOF Q1 2026 Earnings Net Loss of 012 Per Share Stock Declines 217 NYT Q1 2026 Earnings EPS Surges Past Estimates with 2746 Surprise DBRG Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Higher MELI Q1 2026 Earnings EPS Miss Despite Strong Operational Momentum BioLineRx Ltd BLRX Q3 2024 Earnings Loss Per Share of 007 on No Revenue Shares Surge 9 Jazz Pharmaceuticals JAZZ Holds Flat Near Key Resistance Amid LowVolume Consolidation LivePerson LPSN Hovers Near Support as Uptrend Faces Resistance at 225 BHFAO Preferred Shares Hold Steady at 1601 Amid Narrow Trading Range First US Bancshares FUSB Edges Lower as Stock Nears Key Support Level Chevron CVX Holds Steady Near Key Resistance Levels Amid Modest Gains Artificial Intelligence and Quarterly Earnings Reports A Macro Perspective from The Big Picture PagSeguro Digital PAGS Q1 2026 Earnings EPS Miss Sends Stock Lower Big Tree Cloud Holdings DSY Gains 74 as Shares Test Resistance Near 214 North American Construction Group NOA Climbs 235 as Volume Picks Up Eyes Resistance at 1554 Vistagen Therapeutics VTGN Approaches Key Support After Marginal Decline HireQuest Inc HQI Holds Steady at 1269 with Key Support and Resistance in Focus Newegg Commerce NEGG Slips 44 as Resistance Holds Above 1950 Millennium Group International Holdings MGIH Holds Steady at 142 as Key Levels Define Trading Range KT Corporation KT Dips 15 as Telecommunications Sector Faces Headwinds Ligand Pharmaceuticals LGND Gains Momentum Approaching Key Resistance at 2408